Table 3.

Unstandardized parameter estimates from growth models for each inflammatory marker.

Parameter	IL-6	TNF-α	CRP
Unconditional Model
Mean Intercept	0.59 (0.92)	3.82 (0.99)^*	−3.67 (2.19)
Mean Slope	0.01 (0.20)	0.04 (0.16)	−0.01 (0.24)
Intercept Variance	2.25 (1.48)	1.54 (0.98)	20.36 (8.36)^*
Slope Variance	0.03 (0.04)	0.04 (0.05)	0^a
Intercept/Slope Covariance	−0.21 (0.17)	0.05 (0.11)	0^a
Residual Variance: Baseline	1.84 (1.39)	3.48 (1.14)^*	28.39 (12.97)^*
Residual Variance: Week 3	5.04 (2.25)^*	5.49 (2.45)^*	1.17 (2.24)
Residual Variance: Week 10	6.62 (4.40)	0.38 (3.92)	7.10 (3.27)^*
Conditional Model
Mean Intercept	−0.12 (0.88)	4.22 (0.99)^*	−3.78 (2.04)
Mean Slope	0.18 (0.20)	0.04 (0.18)	<0.01 (0.27)
Intercept Variance	1.88 (1.41)	1.57 (0.97)	20.34 (8.31)^*
Slope Variance	0.02 (0.03)	0.04 (0.05)	0^a
Intercept/Slope Covariance	−0.16 (0.16)	0.03 (0.10)	0^a
Intercept on treatment	0.86 (0.42)^*	−0.54 (0.46)	0.15 (1.11)
Slope on treatment	−0.24 (0.09)^*	−0.01 (0.08)	−0.02 (0.10)
Residual Variance: Baseline	2.10 (1.31)	3.35 (1.12)^*	28.41 (13.07)^*
Residual Variance: Week 3	5.06 (2.24)	5.54 (2.47)^*	1.17 (2.25)
Residual Variance: Week 10	5.66 (3.89)	0.15 (3.89)	7.10 (3.30)^*

= parameter fixed to 0 due to low variance,

= p < .05